GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,514,000 | -90.5% | 100,000 | -86.3% | 0.14% | -95.1% |
| Q4 2019 | $58,028,000 | -39.1% | 730,000 | -59.4% | 2.95% | -37.8% |
| Q1 2019 | $95,274,000 | +3.2% | 1,800,000 | -20.0% | 4.75% | +8.3% |
| Q4 2018 | $92,363,000 | +17.1% | 2,250,000 | +8.4% | 4.38% | +29.9% |
| Q3 2018 | $78,850,000 | -20.7% | 2,075,000 | -5.7% | 3.37% | -11.8% |
| Q2 2018 | $99,440,000 | +71.6% | 2,200,000 | +83.3% | 3.83% | +34.4% |
| Q1 2018 | $57,960,000 | +84.1% | 1,200,000 | +50.0% | 2.85% | +84.7% |
| Q4 2017 | $31,480,000 | – | 800,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |